We unexpectedly found a strong association between the probability of decrease in phosphorylation of PDGFR in peripheral blood leukocytes and rising plasma PDGF isoform concentrations with inferior PFS and overall survival following docetaxel plus placebo therapy in men with castration-resistant prostate cancer. This evidence concerns the gene PDGFRB and prostate carcinoma.